Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Rajat Bose of rajatkbose.com is of the view that one can buy Cipla, Wockhardt and Power Grid.
In an interview to CNBC-TV18, SP Tulsian of sptulsian.com explains why he likes the two wheeler space. He also explains why it is now the best time to book profits on TVS Motor. He talks about Orient Paper's demerger and shares his views on its restructuring.
Ruchit Jain of Angel Broking recommends buying Cox & Kings with target of Rs 214 and IPCA Labs with target of Rs 604.
Mitesh Thacker of miteshthacker.com recommends selling Larsen & Toubro and advises buying Wockhardt.
According to Mitesh Thacker of miteshthacker.com, one can buy Sanghi Industries, Axis Bank and Natco Pharma.
Manish Sharma of derivativetradingresearch is of the view that one may buy Havells India with a target of Rs 420.
Sharmila Joshi of sharmilajoshi.com is of the view that one may stay invested in pharma space with long term view.
Here are brokerage firms views on six stocks. Motilal downgrades Hero MotoCorp to neutral from buy given rich valuations. Target for the stock is at Rs 3666 per share. It says volume growth drives revenue as adverse mix dragged realisations.
On Bharat Electrical Ltd (BEL), Prakash Diwan of prakashdiwan.in said, "If there is a little bit of a sell-off, you could probably buy into the stock and accumulate it".
Sudarshan Sukhani of s2analytics.com recommends buying Tata Coffee and expects higher levels in the stock.
Deutsche Bank raises FY17/FY18 forecast on Hindalco by 2 percent/7 percent. It raises target price by 14 percent to Rs 156 per share, reiterating buy call. Novelis reports strong Q1 earnings.
Gaurav Bissa of LKP Securities is of the view that one can go long in ITC 260 Call and Wockhardt 700 Call.
CA Rudramurthy BV of Vachana Investments recommends buying Wockhardt and Aurobindo Pharma.
In an interview to CNBC-TV18 Mayuresh Joshi of Angel Broking shared his reading and outlook on the market as well as on various stocks and sectors.
SP Tulsian of sptulsian.com in an interview to CNBC-TV18 shared his rationale behind turning cautious on cement stocks.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Wockhardt, Edelweiss Financial Services and Uflex.
Sandeep Wagle of powermywealth.com is of the view that one can buy JSW Energy, Wockhardt and Aditya Birla Nuvo.
In an interview to CNBC-TV18, SP Tulsian of sptulsian.com shared his reading and outlook on the fundamental side of the market as well as on specific stocks and sectors.
In an interview to CNBC-TV18's Anuj Singhal and Sonia Shenoy, SP Tulsian of sptulsian.com shared his reading and outlook on the market and also gave recommendations on various stocks.
In an interview with CNBC-TV18, market expert, SP Tulsian gave his stock picks and told why he is bullish on pharma stocks for the month of July.
In an interview with CNBC-TV18, market expert, SP Tulsian gave his stock picks for the day and talked about the listing of Mahanagar Gas on the Indian bourse.
In an interview with CNBC-TV18, market expert, SP Tulsian gave his stock picks and told why he has a positive stance on all pharma stocks for this coming month.
Gaurav Bissa of LKP Securities is of the view that one may buy Bharti Infratel with a target of Rs 350.
I won‘t be surprised to see pharma as the story for July series and won‘t be surprised in seeing a big upsurge in all big pharma, said SP Tulsian.
SP Tulsian of sptulsian.com recommends going long in Lupin, Glenmark Pharma, Aurobindo Pharma and Strides Shasun.